Jul 1 |
Nuwellis files for $25M mixed securities shelf
|
Jun 26 |
Nuwellis to implement 1-for-35 reverse stock split
|
Jun 26 |
Nuwellis Announces Reverse Stock Split
|
Jun 25 |
Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™
|
Jun 6 |
Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase
|
May 14 |
Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida
|
May 9 |
Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy
|
May 7 |
Nuwellis, Inc. (NUWE) Q1 2024 Earnings Call Transcript
|
May 7 |
Nuwellis, Inc. 2024 Q1 - Results - Earnings Call Presentation
|
May 7 |
Nuwellis GAAP EPS of -$0.60, revenue of $1.86M
|